This article notes the FDA is allowing Gilead to proceed with an investigation into prescribing Yeztugo as a weekly, oral PrEP med. It's already approved as a bridge between normal PrEP medications & the long acting, injection of Yeztugo or lenacapavir.
If successful, it will be another option for prevention. Some people may want or not tolerate the long acting injections for PrEP. For them, oral meds may remain the better option. Still, weekly means 52 doses not 365. That's over 300 less pills & chances to miss the dose.
This was a good article, give it a read. Take care.
Cya...
No comments:
Post a Comment